Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Eberhardt

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
IJTLD Open|January 19, 2026
Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocolM Gödecke, F Eberhardt, G Barten-Neiner, et al.
European Journal of Medical Research|April 22, 2009
The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart diseaseMatthias Heringlake, T Kox, J Poeling, et al.
Cardiovascular Surgery (London, England)|September 28, 1999
Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgeryU Mehlhorn, H Sauer, F Kuhn-Régnier, et al.
Scientific Reports|November 30, 2021
Impact of respiratory infectious epidemics on STEMI incidence and careS Macherey, M M Meertens, C Adler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2022
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) PatientsJuliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2021
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) PatientsJuliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Allergy|February 14, 2008
The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantificationR van Ree, M D Chapman, F Ferreira, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
IJTLD Open|January 19, 2026
Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocolM Gödecke, F Eberhardt, G Barten-Neiner, et al.
European Journal of Medical Research|April 22, 2009
The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart diseaseMatthias Heringlake, T Kox, J Poeling, et al.
Cardiovascular Surgery (London, England)|September 28, 1999
Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgeryU Mehlhorn, H Sauer, F Kuhn-Régnier, et al.
Scientific Reports|November 30, 2021
Impact of respiratory infectious epidemics on STEMI incidence and careS Macherey, M M Meertens, C Adler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2022
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) PatientsJuliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2021
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) PatientsJuliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Allergy|February 14, 2008
The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantificationR van Ree, M D Chapman, F Ferreira, et al.
Pageof 2